USANA Health Sciences (USNA) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
9 Nov, 2026Strategic transformation
Shifting from a direct-selling foundation across 25 markets toward an omnichannel wellness platform, with Hiya and Rise expanding into DTC, e-commerce, retail, club and international channels.
Omnichannel brands are expected to contribute ~18% of FY 2026 revenue, with Core Nutritional at ~82%.
Priorities include rebuilding active customers, disciplined capital allocation and applying product, manufacturing, operating and international expertise across the platform.
Core nutritional business
Core Nutritional segment operating margin rose to 4.1% from 1.2% YoY; brand, product and incentive initiatives target active customer growth.
Active customer base is the largest growth lever; initiatives include brand investment, digital marketing, product innovation and incentives tied more directly to active customer growth.
67% of Core Nutritional products are manufactured in-house, supporting supply flexibility, input cost control and margin protection.
The growth playbook combines customer acquisition and retention, Brand Partner enablement, science-led products, vertical integration and selective geographic expansion.
Hiya and Rise Wellness
Hiya offers children’s vitamins and nutrition through a digital-first subscription model; Q3 2026 net sales were $32M, up 2% YoY, with 195,500 active monthly subscribers, up 18% sequentially.
Hiya’s next growth vectors include retail, Amazon, international expansion and new product categories; customer acquisition costs declined in Q3 from the first half of 2026.
Rise Wellness sells clean-label protein products through national retail and club channels; Q3 net sales were $4M, down 45% YoY and up 7% sequentially, following a prior-year large club order that did not repeat.
Rise Wellness revenue is guided at $30M for FY 2026, compared with $16M in FY 2025 and $5M in FY 2024; growth plans include new formats, retail doors, DTC, club and international reach.
Latest events from USANA Health Sciences
- Hiya growth tempered by Core and Rise declines as FY2026 adjusted EBITDA outlook fell to $77M.USNA
Q3 2026 - Q4 EPS rebounded; FY2024 guidance builds in sales pressure and investment costs.USNA
Q4 2023 - Q2 2026 net loss of $21.4M on $223M sales, with Hiya impairment and reduced outlook.USNA
Q2 2026 - Emerging brands Hiya and Rise Wellness are set to drive significant revenue growth and diversification in FY2026.USNA
Investor presentation - All proposals passed with quorum; directors elected, auditor ratified, and compensation approved.USNA
AGM 2026 - Flat Q1 2026 sales, lower earnings, and strong Rise Wellness growth amid customer declines.USNA
Q1 2026 - Omnichannel growth and acquisitions are set to drive over 20% of revenue by 2026.USNA
28th Annual ICR Conference 2026 - $205M acquisition of Hiya accelerates growth and diversification in children's wellness.USNA
M&A Announcement - Acquisition of Hiya Health accelerates growth in children's supplements and DTC channels.USNA
27th Annual ICR Conference 2025